Tilanthi Jayawardena et al.
Methods in molecular biology (Clifton, N.J.), 1150, 263-272 (2014-04-20)
The therapeutic administration of microRNAs represents an innovative reprogramming strategy with which to advance cardiac regeneration and personalized medicine. Recently, a distinct set of microRNAs was found capable of converting murine fibroblasts to cardiomyocyte-like cells in vitro. Further treatment with